Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms 44Sc-DOTA-[3-Tyr]-octreotide, SC44-DOTATOC |
Target |
Action agonists |
Mechanism SSTR agonists(Somatostatin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroendocrine Tumors | Clinical | Germany | 01 May 2015 |
Not Applicable | - | 44Sc-DOTATOC | wspgswvpbv(kikgfsynig) = No adverse effects were observed in any of the patients khctvbaxvf (nwqrsdbgim ) View more | - | 15 May 2015 |